Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial
出版年份 2020 全文链接
标题
Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial
作者
关键词
-
出版物
Trials
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-13
DOI
10.1186/s13063-020-4202-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Familial Cerebral Cavernous Malformations
- (2019) Atif Zafar et al. STROKE
- Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation
- (2019) Alan T. Tang et al. Science Translational Medicine
- Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial
- (2018) Sean P Polster et al. NEUROSURGERY
- Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults: systematic review and meta-analysis
- (2018) Lorna M Gibson et al. BMJ-British Medical Journal
- Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations
- (2017) Romuald Girard et al. JOURNAL OF NEUROSURGERY
- Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis
- (2017) Bradley A. Gross et al. JOURNAL OF NEUROSURGERY
- Endothelial TLR4 and the microbiome drive cerebral cavernous malformations
- (2017) Alan T. Tang et al. NATURE
- Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel
- (2017) Amy Akers et al. NEUROSURGERY
- Efficient Trial Design — FDA Approval of Valbenazine for Tardive Dyskinesia
- (2017) Michael C. Davis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations
- (2017) Romuald Girard et al. Translational Stroke Research
- Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults
- (2017) Kelly D. Flemming et al. JAMA Neurology
- Degradation dynamics of microRNAs revealed by a novel pulse-chase approach
- (2016) Matteo J. Marzi et al. GENOME RESEARCH
- Safety of Propranolol Therapy for Severe Infantile Hemangioma
- (2016) Sorilla Prey et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognosis of cerebral cavernomas: on to treatment decisions
- (2016) Ale Algra et al. LANCET NEUROLOGY
- Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data
- (2016) Margaret A Horne et al. LANCET NEUROLOGY
- Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage
- (2016) Joseph M. Zabramski et al. World Neurosurgery
- Vascular Permeability in Cerebral Cavernous Malformations
- (2015) Abdul G Mikati et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma
- (2015) Christine Léauté-Labrèze et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of Iron Content in Human Cerebral Cavernous Malformation Using Quantitative Susceptibility Mapping
- (2014) Huan Tan et al. INVESTIGATIVE RADIOLOGY
- Successful treatment of multifocal intracerebral and spinal hemangiomas with propranolol
- (2014) Juliette Miquel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Non-coding RNAs in cerebral endothelial pathophysiology: Emerging roles in stroke
- (2014) Ke-Jie Yin et al. NEUROCHEMISTRY INTERNATIONAL
- Outcome after surgical or conservative management of cerebral cavernous malformations
- (2014) F. Moultrie et al. NEUROLOGY
- Propranolol for Cerebral Cavernous Angiomatosis
- (2013) Irene Berti et al. CLINICAL PEDIATRICS
- EndMT contributes to the onset and progression of cerebral cavernous malformations
- (2013) Luigi Maddaluno et al. NATURE
- Sample size calculations for pilot randomized trials: a confidence interval approach
- (2012) Kim Cocks et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference
- (2012) B. A. Drolet et al. PEDIATRICS
- Propranolol, a very promising treatment for ulceration in infantile hemangiomas: A study of 20 cases with matched historical controls
- (2011) Denise Josephina Johanna Hermans et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Propranolol Treatment for a Giant Infantile Brain Cavernoma
- (2010) Maria Moschovi et al. JOURNAL OF CHILD NEUROLOGY
- The role and interpretation of pilot studies in clinical research
- (2010) Andrew C. Leon et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Update on the natural history of cavernous malformations and factors predicting aggressive clinical presentation
- (2010) Chad W. Washington et al. Neurosurgical Focus
- Stabilization of VEGFR2 Signaling by Cerebral Cavernous Malformation 3 Is Critical for Vascular Development
- (2010) Y. He et al. Science Signaling
- The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological Implications
- (2009) Elisabetta Dejana et al. DEVELOPMENTAL CELL
- A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells
- (2008) Axel Pagenstecher et al. HUMAN MOLECULAR GENETICS
- Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis
- (2008) Amy L. Akers et al. HUMAN MOLECULAR GENETICS
- Hemorrhage From Cavernous Malformations of the Brain
- (2008) Rustam Al-Shahi Salman et al. STROKE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started